Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials

Martin Geroldinger(Paracelsus Medical University), Georg Zimmermann(University of Salzburg), Arne C. Bathke(University of Salzburg), Andrew C. Hooker(Uppsala University), Martin Laimer(Paracelsus Medical University), Verena Wally(Paracelsus Medical University), Joakim Nyberg(Uppsala University), Johan Verbeeck(Hasselt University), Konstantin Emil Thiel(Paracelsus Medical University), Geert Molenberghs(University of Antwerp), Johann Bauer(Universität Innsbruck)
Orphanet Journal of Rare Diseases
December 19, 2023
10.1186/s13023-023-02990-1
Cited by 4

Related Papers

Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
|Journal of the American Academy of Dermatology|2014|933
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB
|Journal of the American Academy of Dermatology|2008|933
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
|British Journal of Dermatology|2020|778
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
|The Lancet|2022|408